BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shukla A, Shreshtha A, Mukund A, Bihari C, Eapen CE, Han G, Deshmukh H, Cua IHY, Lesmana CRA, Al Meshtab M, Kage M, Chaiteeraki R, Treeprasertsuk S, Giri S, Punamiya S, Paradis V, Qi X, Sugawara Y, Abbas Z, Sarin SK. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2021;15:531-67. [PMID: 34240318 DOI: 10.1007/s12072-021-10189-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Elkilany A, Alwarraky M, Denecke T, Geisel D. Percutaneous transluminal angioplasty for symptomatic hepatic vein-type Budd-Chiari syndrome: feasibility and long-term outcomes. Sci Rep 2022;12:14095. [PMID: 35982064 DOI: 10.1038/s41598-022-16818-8] [Reference Citation Analysis]
2 Li Z, Wang L, Yi F, Qi X. Rapid development of gingival bleeding after rivaroxaban in a patient with Budd-Chiari syndrome. Liver Int 2021;41:2236-7. [PMID: 34297477 DOI: 10.1111/liv.15021] [Reference Citation Analysis]